Physiomics
Oxford
About Physiomics
Physiomics plc combines systems biology with cutting edge mathematics to develop models that streamline the drug discovery and development process. Virtual Tumour, the company’s lead service, is used to optimise the dosing and scheduling of oncology drugs in pre-clinical and clinical trials. This optimisation improves the efficacy of combinations and streamlines the drug development process.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $192.1K
- Funding stage: IPO
- Last round: Grant (Nov 2023)
- Ticker: lse:PYC
- Website: physiomics-plc.com
- Phone: +44 (0) 1865 784980
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/physiomics-2236946 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.